Page last updated: 2024-10-26

disopyramide and Ebstein Anomaly

disopyramide has been researched along with Ebstein Anomaly in 1 studies

Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.

Ebstein Anomaly: A congenital heart defect characterized by downward or apical displacement of the TRICUSPID VALVE, usually with the septal and posterior leaflets being attached to the wall of the RIGHT VENTRICLE. It is characterized by a huge RIGHT ATRIUM and a small and less effective right ventricle.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jackman, WM1
Friday, KJ1
Scherlag, BJ1
Dehning, MM1
Schechter, E1
Reynolds, DW1
Olson, EG1
Berbari, EJ1
Harrison, LA1
Lazzara, R1

Other Studies

1 other study available for disopyramide and Ebstein Anomaly

ArticleYear
Direct endocardial recording from an accessory atrioventricular pathway: localization of the site of block, effect of antiarrhythmic drugs, and attempt at nonsurgical ablation.
    Circulation, 1983, Volume: 68, Issue:5

    Topics: Adult; Anti-Arrhythmia Agents; Atrioventricular Node; Cardiac Pacing, Artificial; Disopyramide; Ebst

1983